972 filings
Page 5 of 49
8-K
l8cn 3bibljarm
8 Dec 22
Other Events
4:03pm
D
fc5m emp7
2 Dec 22
$1.50 mm in equity, sold $1.50 mm, 2 investors
8:09pm
SC 13D/A
uvmusww8i2eaut
2 Dec 22
Acer Therapeutics / Schelling Chris ownership change
4:02pm
4
mw2yseskr9w4h z52j7d
1 Dec 22
Acer Therapeutics / Chris Schelling ownership change
4:02pm
4
vbg ak2f4g8g5h
1 Dec 22
Acer Therapeutics / STEVE ASELAGE ownership change
4:01pm
8-K
c68q9ppoyuu56y
30 Nov 22
Acer Therapeutics Announces $1.5M Private Placement
8:35am
8-K
6h7g891v38efmz
29 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
gm74cyp
14 Nov 22
Acer Therapeutics Reports Q3 2022 Financial Results and Provides Corporate Update
5:09pm
8-K
537sh 0bo
14 Nov 22
Results of Operations and Financial Condition
4:55pm
8-K
bmp 8qpeov3y8
26 Oct 22
Acer Therapeutics Receives Notice of Allowance of Key US Patent Application
9:01am
8-K
ljr4fr5ldfo 59qfqrnr
6 Oct 22
Other Events
9:00am
8-K
mp5amhbvyyj1 jo5
5 Oct 22
Acer Therapeutics Announces Expansion of ACER-801 (osanetant) Development Indications to Include Post-Traumatic Stress Disorder
9:01am
8-K
iwysp8w00 oh8gchrt8j
3 Oct 22
Other Events
9:00am
8-K
m2ar8cy5q5qi
23 Aug 22
Regulation FD Disclosure
4:04pm
8-K
3q337 gkinj0i60sj
23 Aug 22
Entry into a Material Definitive Agreement
8:30am
8-K
y5hmmn8q bh05j1xrr5
15 Aug 22
Acer Therapeutics Reports Q2 2022 Financial Results and Provides Corporate Update
4:14pm
8-K
q13848aq uxhs
12 Aug 22
Orphan designation provides potential for up to 10-year market exclusivity in the EU upon regulatory approval
9:00am